A focused 2026 presale showdown comparing IPO Genie, Bitcoin Hyper, and Nexchain to assess which top presale offers the highest upside.
Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback